DISEASE IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE TAK003 IN THAILAND

被引：0
|
作者：
Shen, J. [1 ]
Kharitonova, E. [2 ]
Biswal, S. [3 ]
Sharma, M. [4 ]
Aballea, S. [2 ]
Tytula, A. [5 ]
Zawieja, J. [5 ]
Towle, P. [6 ]
Hanley, R. [1 ]
机构：
[1] Takeda Int AG, Payer Value & Access, Zurich, Switzerland
[2] Creativ Ceut, HEOR, Paris, France
[3] Takeda Vaccines Inc, Clin Dev, Cambridge, MA USA
[4] Takeda Vaccines Inc, Vaccine Res & Analyt, Cambridge, MA USA
[5] Creativ Ceut, HEOR, Krakow, Poland
[6] Takeda Pharmaceut Asia Pacific Pte Ltd, Market Access, Singapore, Singapore
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2023年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF THE DENGUE VACCINE TAK-003 IN THAILAND
    Shen, J.
    Kharitonova, E.
    Biswal, S.
    Sharma, M.
    Aballea, S.
    Tytula, A.
    Zawieja, J.
    Towle, P.
    Hanley, R.
    Rungmaitree, S.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S162 - S162
  • [2] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE (TAK-003) IN A LARGE CATCH-UP COHORT IN PUERTO RICO
    Shen, J.
    Zerda, I
    Hanley, R.
    Kharitonova, E.
    Janusz, Z.
    Biswal, S.
    Sharma, M.
    Tricou, V
    Kastner, R.
    Wallace, D.
    Rosas, A.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S66 - S66
  • [3] COST OF DENGUE AND COST-EFFECTIVENESS OF THE DENGUE VACCINE IN PANAMA
    Garcia, L. N.
    Cerezo, L.
    Blas, A.
    Alvarez, S.
    Quiroz, N.
    Caicedo, Navas A. G.
    Lopez, J. G.
    Vandeputte, C.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A414 - A414
  • [4] TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden
    Wilder-Smith, Annelies
    [J]. LANCET GLOBAL HEALTH, 2024, 12 (02): : e179 - e180
  • [5] Effectiveness and safety of the tetravalent TAK-003 dengue vaccine: a systematic review
    Bengolea, Agustin
    Scigliano, Clara
    Ramos-Rojas, Jose T.
    Rada, Gabriel
    Catalano, Hugo N.
    Izcovich, Ariel
    [J]. MEDICINA-BUENOS AIRES, 2024, 84 (04) : 689 - 707
  • [6] Cost-effectiveness of a pediatric dengue vaccine
    Shepard, DS
    Suaya, JA
    Halstead, SB
    Nathan, MB
    Gubler, DJ
    Mahoney, RT
    Wang, DNC
    Meltzer, MI
    [J]. VACCINE, 2004, 22 (9-10) : 1275 - 1280
  • [7] Immunogenicity of a Live Dengue Vaccine (TAK-003)
    de Silva, Aravinda
    White, Laura
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01): : 163 - 164
  • [8] COST-EFFECTIVENESS OF THE VACCINE AGAINST DENGUE 2014
    Castro Rodriguez, R.
    Rueda-Gallardo, J. A.
    Avella Nino, M. F.
    Lopez, J. G.
    Caicedo Navas, A. G.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A871 - A872
  • [9] Dengue dynamics and vaccine cost-effectiveness in Brazil
    Durham, David P.
    Mbah, Martial L. Ndeffo
    Medlock, Jan
    Luz, Paula M.
    Meyers, Lauren A.
    Paltiel, A. David
    Galvani, Alison P.
    [J]. VACCINE, 2013, 31 (37) : 3957 - 3961
  • [10] Rotavirus disease in Uzbekistan: Cost-effectiveness of a new vaccine
    Isakbaeva, E. T.
    Musabaev, E.
    Antil, L.
    Rheingans, R.
    Juraev, R.
    Glass, R. I.
    Bresee, J. S.
    [J]. VACCINE, 2007, 25 (02) : 373 - 380
12345